SOMO - The Centre for Research on Multinational Corporations
Feb 12, 2026 · SOMO is a critical, independent, not-for-profit knowledge centre on multinationals. Read more about our most recent research.
About Us - The Centre for Research on Multinationals - SOMO
SOMO investigates multinationals. Independent, factual, and critical, we have a clear goal – a fair and sustainable world in which public interests outweigh corporate interests. Since 1973, as the Centre …
The secretive cabal of US polluters that is rewriting the EU ... - somo.nl
Dec 3, 2025 · Leaked documents reveal how a secretive alliance of eleven large multinational enterprises has worked to tear down the EU’s CSDDD.
SOMO - Stichting Onderzoek Multinationale Ondernemingen
Dec 4, 2025 · SOMO is een kritisch, onafhankelijk kenniscentrum, zonder winstoogmerk, gericht op multinationals. Lees hier ons meest recente onderzoek.
Audited ≠ Ethical: how fashion brands mislead consumers - SOMO
Feb 24, 2026 · SOMO, Consumentenbond, and CCC examined advertisements and statements made by dozens of clothing brands about working conditions in (online) stores, on social media, and on …
How Big Oil kills sustainability and climate legislation - SOMO
Oct 2, 2025 · SOMO's investigation reveals how the world’s largest private oil company mounted a transatlantic lobbying campaign to derail the CSDDD.
CSDDD Datahub - Search for a company - SOMO
The Counter is SOMO’s pro bono research helpdesk, which provides corporate research to activists, communities, trade unions, journalists, and others. Acknowledgements SOMO would like to thank …
Carbon: the new frontier in the scramble for land in Kenya - SOMO
Dec 8, 2025 · SOMO’s investigation shows how the global carbon offset industry is reshaping land ownership, governance, and livelihoods in Kenya, and calls for climate solutions that confront the …
Latest updates - SOMO
Discover the most recent news articles and publications from the Centre for Research on Multinational Corporations, or check our archives.
Big Pharma raked in USD 90 billion in profits with COVID-19 vaccines
Feb 27, 2023 · Pfizer, BioNTech, Moderna, and Sinovac made an extraordinary USD 90 billion in profits on their COVID-19 vaccines in 2021 and 2022.